Press Releases

Explore our latest press releases on corporate developments, strategic collaborations, and progress across our DNA-based therapeutics platform.

2026 - Research Collaboration with Evotec

Plectonic Biotech and Evotec are combining LOGIBODY® precision targeting with CD2-based T cell co-stimulation to explore a new generation of more selective and potent immunotherapies for solid tumors. Read more.

2025 - Strategic Partnership with Sonrai Analytics

Through a new collaboration with Sonrai Analytics, Plectonic Biotech is enhancing the development of its LOGIBODY^® technology by integrating high-resolution, AI-powered antigen discovery to drive safer, more targeted cancer immunotherapies. Read more.